Testing a New Medication for Progressive Lung Scarring Disease

This clinical trial is testing a medication called H01 to see if it can help people with progressive interstitial lung disease — a condition where lung tissue becomes scarred and stiff over time. The medication works by trying to reduce levels of a substance in your blood and lungs that may contribute to lung scarring. Researchers will measure whether the treatment is safe and whether it helps improve how your lungs work.

Progressive interstitial lung disease causes the lungs to become increasingly scarred and fibrotic, making it harder to breathe. Currently, treatment options are limited, so doctors are testing this medication to see if it can slow or reduce lung scarring and help patients maintain better lung function.